Portia Kit
Product Images NDC 0555-9020

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Portia (NDC 0555-9020). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure of Levonorgestrel, the active ingredient in Portia (Levonorgestrel and Ethinyl Estradiol). The diagram shows the molecular structure including rings and functional groups, illustrating the compound's steroidal framework.*

FDA Label Image

Image 2

Chemical structure of Levonorgestrel, the active ingredient in the product Portia. The diagram displays the steroid framework with hydroxyl and methyl groups attached, characteristic of this hormonal compound.*

FDA Label Image

Image 3

A horizontal bar chart comparing the number of women with blood clots per 10,000 women-years across four groups: Non-Pregnant Non-COC users, COC users, Pregnancy, and Postpartum (12 weeks only). The chart shows ranges for each group, highlighting varying blood clot risks associated with each condition.*

FDA Label Image

Image 4

A forest plot chart depicting effect estimates (odds ratios with 95% confidence intervals) from various women's contraceptive and health studies, comparing ever use and current use data. The horizontal axis shows effect estimates from -1.5 to 2, with individual study points and confidence intervals plotted for each study name and year.*

FDA Label Image

Image 5

A vertical chart illustrating pregnancy rates per 100 women per year in relation to contraceptive methods. Methods are categorized from fewer to more pregnancies annually, including implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, no sex during fertile days, spermicide, withdrawal, and no birth control.*

FDA Label Image

Image 6

Portia kit blister pack containing levonorgestrel and ethinyl estradiol tablets USP 0.15 mg/0.03 mg. The pack displays 28 circular tablets arranged in four rows labeled Week 1 through Week 4, with each row representing days Sunday through Saturday. The first 21 tablets are shaded, followed by seven white tablets. Storage instructions indicate 20° to 25°C (68° to 77°F). The labeler is Teva Pharmaceuticals USA, Inc., with NDC 0555-9020.*

FDA Label Image

Image 7

Portia 0.15 mg/0.03 mg kit packaging label shows levonorgestrel and ethinyl estradiol tablets USP. The kit contains 6 blister cards, each with 28 tablets. The label displays the NDC 0555-9020-58, the Teva Pharmaceuticals USA, Inc. logo, and includes information that the product is prescription only. The label background is light purple with striped white sections and includes a barcode and product safety note.*

FDA Label Image

Image 8

Packaging label for Portia (levonorgestrel and ethinyl estradiol tablets USP) 0.15 mg/0.03 mg by Teva Pharmaceuticals USA, Inc. The kit contains 6 blister cards with 28 tablets each. The label includes storage instructions, a QR code for more product information, and usage guidelines for the dispenser. It features the Teva logo and the Shaping Women's Health logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.